Literature DB >> 26334029

Paradoxical Role of IL-17 in Progression of Diabetic Nephropathy.

Daniel L Galvan1, Farhad R Danesh2.   

Abstract

Entities:  

Keywords:  cytokines; diabetic nephropathy; glomerular epithelial cells; kidney

Mesh：

Substances：

Year:  2015        PMID： 26334029      PMCID： PMC4769213          DOI： 10.1681/ASN.2015070813

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  9 in total

Review 1.  IL-17 family: cytokines, receptors and signaling.

Authors:  Chunfang Gu; Ling Wu; Xiaoxia Li
Journal:  Cytokine       Date:  2013-09-03       Impact factor: 3.861

2.  Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression.

Authors:  Su-Mi Kim; Sang-Ho Lee; Arah Lee; Dong-Jin Kim; Yang-Gyun Kim; Se-Yun Kim; Kyung-Hwan Jeong; Tae-Won Lee; Chun-Gyoo Ihm; Sung-Jig Lim; Ju-Young Moon
Journal:  Transl Res       Date:  2015-05-05       Impact factor: 7.012

3.  Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.

Authors:  Martin A Kriegel; Esen Sefik; Jonathan A Hill; Hsin-Jung Wu; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

4.  Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.

Authors:  Kimiko Nakajima; Takashi Kanda; Mikiro Takaishi; Takeo Shiga; Ken Miyoshi; Hideki Nakajima; Reiko Kamijima; Masahito Tarutani; Jacqueline M Benson; M Merle Elloso; Lester L Gutshall; Michael F Naso; Yoichiro Iwakura; John DiGiovanni; Shigetoshi Sano
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

5.  IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Yan Hu; Naruhisa Ota; Ivan Peng; Canio J Refino; Dimitry M Danilenko; Patrick Caplazi; Wenjun Ouyang
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

6.  Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension.

Authors:  Christian F Krebs; Sascha Lange; Gianina Niemann; Alva Rosendahl; Alexander Lehners; Catherine Meyer-Schwesinger; Rolf A K Stahl; Ralf A Benndorf; Joachim Velden; Hans-Joachim Paust; Ulf Panzer; Heimo Ehmke; Ulrich O Wenzel
Journal:  Hypertension       Date:  2013-12-23       Impact factor: 10.190

7.  Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.

Authors:  Riyaz Mohamed; Calpurnia Jayakumar; Feng Chen; David Fulton; David Stepp; Ron T Gansevoort; Ganesan Ramesh
Journal:  J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 10.121

8.  Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse.

Authors:  G Kuriya; T Uchida; S Akazawa; M Kobayashi; K Nakamura; T Satoh; I Horie; E Kawasaki; H Yamasaki; L Yu; Y Iwakura; H Sasaki; Y Nagayama; A Kawakami; N Abiru
Journal:  Diabetologia       Date:  2013-05-23       Impact factor: 10.122

9.  High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression.

Authors:  Prabhakaran Kumar; Kartiga Natarajan; Narkunaraja Shanmugam
Journal:  Cell Signal       Date:  2013-12-02       Impact factor: 4.315
  9 in total
  8 in total

Review 1.  Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.

Authors:  Sandra Rayego-Mateos; José Luis Morgado-Pascual; Lucas Opazo-Ríos; Melania Guerrero-Hue; Cristina García-Caballero; Cristina Vázquez-Carballo; Sebastián Mas; Ana Belén Sanz; Carmen Herencia; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

2.  Longitudinal Analysis of Serum Cytokine Levels and Gut Microbial Abundance Links IL-17/IL-22 With Clostridia and Insulin Sensitivity in Humans.

Authors:  Xin Zhou; Jethro S Johnson; Daniel Spakowicz; Wenyu Zhou; Yanjiao Zhou; Erica Sodergren; Michael Snyder; George M Weinstock
Journal:  Diabetes       Date:  2020-05-04       Impact factor: 9.461

3.  Interleukin 17A promotes diabetic kidney injury.

Authors:  Jin Ma; Yan J Li; Xiaochen Chen; Tony Kwan; Steven J Chadban; Huiling Wu
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

Review 4.  Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications.

Authors:  Javier Donate-Correa; Carla M Ferri; Fátima Sánchez-Quintana; Atteneri Pérez-Castro; Ainhoa González-Luis; Ernesto Martín-Núñez; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  Front Med (Lausanne)       Date:  2021-01-22

Review 5.  Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control.

Authors:  Tsvetelina V Velikova; Plamena P Kabakchieva; Yavor S Assyov; Tsvetoslav А Georgiev
Journal:  Biomed Res Int       Date:  2021-09-13       Impact factor: 3.411

6.  Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.

Authors:  Alieh Gholaminejad; Mohammad Fathalipour; Amir Roointan
Journal:  BMC Nephrol       Date:  2021-07-02       Impact factor: 2.388

Review 7.  Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?

Authors:  Carolina Lavoz; Sandra Rayego-Mateos; Macarena Orejudo; Lucas Opazo-Ríos; Vanessa Marchant; Laura Marquez-Exposito; Antonio Tejera-Muñoz; Juan F Navarro-González; Alejandra Droguett; Alberto Ortiz; Jesús Egido; Sergio Mezzano; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

8.  IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice.

Authors:  Kyung-Hyun Kim; Geum-Lan Hong; Da-Young Jung; Shanika Karunasagara; Won-Il Jeong; Ju-Young Jung
Journal:  Mol Med       Date:  2021-03-10       Impact factor: 6.354
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.